GlaxoSmithKline to shut down Shanghai R&D lab

By Nell Walker
Despite a former status as a hub of scientific innovation, GlaxoSmithKline is set to close its Shanghai R&D centre. The lab had been leading GSK...

Despite a former status as a hub of scientific innovation, GlaxoSmithKline is set to close its Shanghai R&D centre.

The lab had been leading GSK’s research in neurological diseases like Alzheimer’s, Parkinson’s and multiple sclerosis. The company has stated:

“Following a portfolio review and prioritisation, we have decided to close our neuroscience R&D centre in Shanghai and move key programs to our global R&D hub in Upper Providence in the US, where they will benefit from colocation with other pipeline R&D programs.”

This news comes just a couple of weeks after the announcement that the business is selling its rare diseases business as part of its £1bn cost-cutting drive.

GSK began investing in China ten years ago, and had high hopes from the beginning that it would be a shining jewel of the business. A global leader in multiple sclerosis research, Jingwu Zang, led the centre but was fired in 2013 before a wider controversy hit. Eventually, 110 staff in China were fired due to ethical violations, and GSK was forced to pay $500mn to the Chinese government.

This series of events has led to this Shanghai closure, GlaxoSmithKline has said that despite the closure of this particular lab, business in China will continue:

“The China R&D development organization will continue to be based in Shanghai and is set to expand over the next two years to accelerate the development of new medicines,” the firm said. “We remain committed to China and will focus our R&D efforts in China on the needs of China, at both our Shanghai site and our Institute for Infectious Diseases & Public Health in Beijing.”

Share

Featured Articles

5 minutes with: Simon Michie, Pulsant CTO

Simon Michie, CTO at Pulsant, explains why edge computing will transform manufacturing operations, but success will depend on having partnerships in place

Microsoft’s Çağlayan Arkan explores the supply chain

Çağlayan Arkan, Microsoft’s VP Global Strategy & Sales Lead for Manufacturing & Supply Chain, gives his take on digital factories and ‘the art of possible’

Elisabeth Brinton on the Microsoft Cloud for Sustainability

Microsoft’s Elisabeth Brinton discusses the Microsoft Cloud for Sustainability programme & how manufacturers are being supported by their new technology

Aiimi’s Head of Solution Engineering Matt Eustace on risks

AI & Automation

5 minutes with Nicolai Peitersen, co-founder of Wikifactory

Procurement & Supply Chain

Three steps to building a resilient enterprise ecosystem

Procurement & Supply Chain